Last 36.60 TWD
Change Today -0.99 / -2.63%
Volume 17.0K
As of 1:59 AM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for taiwan advance bio-pharmaceu (4186)

Year over year, Taiwan Advance Bio-Pharmaceutical Inc. has seen revenues shrink from 209.7M TWD to 163.5M TWD, though the company was able to grow net income from 19.0M TWD to 18.2M TWD. A reduction in the percentage of sales devoted to income tax expense from 0.04% to -0.51% was a key component in the bottom line growth in the face of falling revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Taiwan Dollars
As of:Dec 31
2010
TWD
Dec 31
2011
Reclassified
TWD
Dec 31
2012
Restated
TWD
Dec 31
2013
TWD
4 Year
Trend
Revenues139.9192.0209.7163.5
Other Revenues1.10.6----
TOTAL REVENUES141.0192.6209.7163.5
Cost of Goods Sold53.579.676.371.4
GROSS PROFIT87.5113.0133.492.1
Selling General & Admin Expenses, Total126.1128.9163.7135.4
R&D Expenses45.022.840.139.8
OTHER OPERATING EXPENSES, TOTAL171.0151.8203.8175.2
OPERATING INCOME-83.5-38.8-70.4-83.1
Interest Expense-1.5-0.9-1.1-1.8
Interest and Investment Income1.21.21.52.4
NET INTEREST EXPENSE-0.30.30.40.6
Income (Loss) on Equity Investments--2.91.7-3.5
Currency Exchange Gains (Loss)-5.61.5-1.51.5
Other Non-Operating Income (Expenses)6.54.96.93.2
EBT, EXCLUDING UNUSUAL ITEMS-82.9-29.2-62.9-81.4
Gain (Loss) on Sale of Investments53.40.543.999.8
Gain (Loss) on Sale of Assets-0.5-0.3---1.0
EBT, INCLUDING UNUSUAL ITEMS-30.0-29.0-18.917.3
Income Tax Expense18.90.80.1-0.8
Minority Interest in Earnings40.6------
Earnings from Continuing Operations-48.9-29.8-19.018.2
NET INCOME-8.3-29.8-19.018.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-8.3-29.8-19.018.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-8.3-29.8-19.018.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4186:TT 36.60 TWD -0.99

4186 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4186.
View Industry Companies
 

Industry Analysis

4186

Industry Average

Valuation 4186 Industry Range
Price/Earnings 100.0x
Price/Sales 12.3x
Price/Book 5.3x
Price/Cash Flow 157.4x
TEV/Sales 11.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIWAN ADVANCE BIO-PHARMACEU, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.